RS50903B - Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera - Google Patents

Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera

Info

Publication number
RS50903B
RS50903B YUP-437/00A YU43700A RS50903B RS 50903 B RS50903 B RS 50903B YU 43700 A YU43700 A YU 43700A RS 50903 B RS50903 B RS 50903B
Authority
RS
Serbia
Prior art keywords
ulcers
denotes
atoms
carbon atoms
alkyl
Prior art date
Application number
YUP-437/00A
Other languages
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Sanofi-Aventis Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh. filed Critical Sanofi-Aventis Deutschland Gmbh.
Publication of YU43700A publication Critical patent/YU43700A/sh
Publication of RS50903B publication Critical patent/RS50903B/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Primenu pudera i bar jednog l-hidrokis-2-piridona prema formuli Iu kojoj su R1, R2 i R3 isti ili različiti, i predstavljaju atom vodonika ili alkil sa 1 do 4 atoma ugljenika;i R4 pretstavlja zasićen ugljenovodonični ostatak sa 6 do 9 atoma ugljenika ili ostatak formule IIpri čemuX označava S ili O,Y označava atom vodonika ili do dva atoma halogena kao što su hlor i/ili brom, Z označava jednovalentu vezu ili dvostruke ostatke O, S, -CR2-, pri čemu Roznačava atom vodonika ili C1-C4-alkil, ili druge dvostruke ostatke sa lancem od 2 do 10 spojenih atoma ugljenika i eventualno atome kiseonika i/ili sumpora, pri čemu kada ostaci sadrže dva ili više atoma vodonika i/ili sumpora oni moraju biti međusobno razdvojeni sa bar 2 susedna atoma ugljenika i koji takođe mogu biti međusobno povezani dvostrukom vezom i slobodne valence atoma ugljenika su zasićene vodonikom i/ili C1-C4-alkil grupama, Ar je aromatični prstenasti sistem sa do dva prstena koji mogu biti supstituisani sa do tri ostatka iz grupe fluor, hlor, brom, metoksi, C1-C4-alkil, trifluormetil i trifluormetoksi,za dobijanje leka za terapiju ulkusa potkolenice i/ili dekubitusnog ulcera.Prijava sadrži još 7 patentnih zahteva.
YUP-437/00A 1998-01-24 1999-01-11 Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera RS50903B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren

Publications (2)

Publication Number Publication Date
YU43700A YU43700A (sh) 2003-08-29
RS50903B true RS50903B (sr) 2010-08-31

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-437/00A RS50903B (sr) 1998-01-24 1999-01-11 Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera

Country Status (28)

Country Link
US (1) US6534528B1 (sr)
EP (1) EP1049468B1 (sr)
JP (1) JP5127091B2 (sr)
KR (1) KR100597332B1 (sr)
CN (1) CN1128619C (sr)
AR (1) AR016445A1 (sr)
AT (1) ATE360418T1 (sr)
AU (1) AU752406B2 (sr)
BR (1) BR9907734A (sr)
CA (1) CA2319359C (sr)
CY (1) CY1106684T1 (sr)
DE (2) DE19802708A1 (sr)
DK (1) DK1049468T3 (sr)
ES (1) ES2285829T3 (sr)
HK (1) HK1034447A1 (sr)
HR (1) HRP20000496A2 (sr)
HU (1) HU228824B1 (sr)
IL (1) IL137453A (sr)
ME (1) MEP55908A (sr)
NZ (1) NZ505898A (sr)
PL (1) PL192550B1 (sr)
PT (1) PT1049468E (sr)
RS (1) RS50903B (sr)
RU (1) RU2212239C2 (sr)
SI (1) SI1049468T1 (sr)
SK (1) SK285350B6 (sr)
TR (1) TR200002118T2 (sr)
WO (1) WO1999037300A1 (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
CN103118973B (zh) * 2010-07-27 2016-03-23 科莱恩金融(Bvi)有限公司 羟基吡啶酮或其盐用于稳定化过氧化氢或释放过氧化氢的物质的用途
ES2525387T3 (es) * 2010-07-27 2014-12-23 Clariant Finance (Bvi) Limited Composiciones que contienen peróxido de hidrógeno o sustancias que ponen en libertad peróxido de hidrógeno
EP3280433B1 (en) 2015-04-06 2021-09-15 Subdomain, LLC De novo binding domain containing polypeptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
DE3779352D1 (de) * 1986-04-18 1992-07-02 Hoechst Ag 1-hydroxy-2-pyridone, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten, sowie bei der herstellung der 1-hydroxy-2-pyridone gebildete zwischenprodukte.
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
AU7695596A (en) * 1995-12-04 1997-06-27 Hoechst Aktiengesellschaft Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat

Also Published As

Publication number Publication date
ME00390B (me) 2011-05-10
CN1288380A (zh) 2001-03-21
BR9907734A (pt) 2000-10-17
JP2002501020A (ja) 2002-01-15
PT1049468E (pt) 2007-05-31
KR100597332B1 (ko) 2006-07-10
AU752406B2 (en) 2002-09-19
KR20010034325A (ko) 2001-04-25
CA2319359A1 (en) 1999-07-29
CA2319359C (en) 2008-03-18
DK1049468T3 (da) 2007-07-30
CY1106684T1 (el) 2012-05-23
ATE360418T1 (de) 2007-05-15
SI1049468T1 (sl) 2007-08-31
PL192550B1 (pl) 2006-11-30
CN1128619C (zh) 2003-11-26
HUP0200851A1 (hu) 2002-07-29
AR016445A1 (es) 2001-07-04
EP1049468B1 (de) 2007-04-25
HUP0200851A3 (en) 2003-05-28
MEP55908A (en) 2011-05-10
AU2278799A (en) 1999-08-09
NZ505898A (en) 2002-06-28
JP5127091B2 (ja) 2013-01-23
SK285350B6 (sk) 2006-11-03
EP1049468A1 (de) 2000-11-08
DE19802708A1 (de) 1999-07-29
RU2212239C2 (ru) 2003-09-20
SK10892000A3 (sk) 2000-12-11
IL137453A (en) 2005-11-20
ES2285829T3 (es) 2007-11-16
HK1034447A1 (en) 2001-10-26
PL342055A1 (en) 2001-05-21
TR200002118T2 (tr) 2000-12-21
IL137453A0 (en) 2001-07-24
DE59914312D1 (de) 2007-06-06
US6534528B1 (en) 2003-03-18
HRP20000496A2 (en) 2000-12-31
YU43700A (sh) 2003-08-29
WO1999037300A1 (de) 1999-07-29
HU228824B1 (en) 2013-05-28

Similar Documents

Publication Publication Date Title
US4446113B1 (sr)
HUP9901590A2 (hu) Szubsztituált aza- és diaza-cikloheptán- és -ciklooktán-származékok, alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
HRP20040317A2 (en) 1,8-naphthyridine derivatives as antidiabetics
ATE263157T1 (de) Nematizide trifluorbutene
ES2071334T3 (es) Analogos de anillos fusionados de nitrogeno conteniendo heterociclos no aromaticos.
YU74792A (sh) Herbicidi
RS50903B (sr) Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera
YU49494B (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcije kože
RS49801B (sr) Primena 1-hidroksi-2-piridona za lečenje seboreičnog dermatitisa
HUP0002861A2 (hu) Benzotiofénszármazékok és ezeket tartalmazó készítmények
ES2127862T3 (es) Preparados cosmeticos que contienen 1-hidroxi-2-piridonas como agentes anticaspa y desodorantes.
HRP20050126B1 (en) Dithianon-based fungicidal mixtures
SE0400441D0 (sv) Novel Benzofurans and Indols
ATE208761T1 (de) Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen
YU126791A (sh) Supstituisani piroli